- Home
- ETON vs PERI Comparison
ETON vs PERI Comparison
Compare ETON & PERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | PERI |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.9M | 412.5M |
| IPO Year | 2018 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ETON | PERI |
|---|---|---|
| Price | $19.01 | $8.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $31.00 | $14.75 |
| AVG Volume (30 Days) | 285.9K | ★ 404.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,011,000.00 | N/A |
| Revenue This Year | $107.23 | $9.95 |
| Revenue Next Year | $29.72 | $1.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 23.29 | N/A |
| 52 Week Low | $11.09 | $7.00 |
| 52 Week High | $23.00 | $11.44 |
Technical Indicators
Market Signals| Indicator | ETON | PERI |
|---|---|---|
| Relative Strength Index (RSI) | 65.46 | 48.67 |
| Support Level | $16.23 | $8.21 |
| Resistance Level | $20.01 | $9.57 |
| Average True Range (ATR) | 1.11 | 0.26 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 72.64 | 58.10 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About PERI Perion Network Ltd.
Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.